167 related articles for article (PubMed ID: 30629018)
1. Medicaid Expansion and Prescription Trends: Opioids, Addiction Therapies, and Other Drugs.
Cher BAY; Morden NE; Meara E
Med Care; 2019 Mar; 57(3):208-212. PubMed ID: 30629018
[TBL] [Abstract][Full Text] [Related]
2. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
[TBL] [Abstract][Full Text] [Related]
3. Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.
Saloner B; Levin J; Chang HY; Jones C; Alexander GC
JAMA Netw Open; 2018 Aug; 1(4):e181588. PubMed ID: 30646116
[TBL] [Abstract][Full Text] [Related]
4. Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states.
Swartz JA; Beltran SJ
Addiction; 2019 Nov; 114(11):2016-2025. PubMed ID: 31286610
[TBL] [Abstract][Full Text] [Related]
5. Medicaid expansion and opioid deaths.
Averett SL; Smith JK; Wang Y
Health Econ; 2019 Dec; 28(12):1491-1496. PubMed ID: 31762149
[TBL] [Abstract][Full Text] [Related]
6. Association between state Medicaid expansion status and naloxone prescription dispensing.
Sohn M; Talbert JC; Delcher C; Hankosky ER; Lofwall MR; Freeman PR
Health Serv Res; 2020 Apr; 55(2):239-248. PubMed ID: 32030751
[TBL] [Abstract][Full Text] [Related]
7. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
8. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
Jayawardhana J; Abraham AJ; Perri M
J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
[TBL] [Abstract][Full Text] [Related]
9. Impact of Medicaid Expansion on Access to Opioid Analgesic Medications and Medication-Assisted Treatment.
Sharp A; Jones A; Sherwood J; Kutsa O; Honermann B; Millett G
Am J Public Health; 2018 May; 108(5):642-648. PubMed ID: 29565661
[TBL] [Abstract][Full Text] [Related]
10. Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.
Springer R; Marino M; Bailey SR; Angier H; O'Malley JP; Hoopes M; Lindner S; DeVoe JE; Huguet N
Addiction; 2019 Oct; 114(10):1775-1784. PubMed ID: 31106483
[TBL] [Abstract][Full Text] [Related]
11. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
12. Prescription Drug Utilization and Reimbursement Increased Following State Medicaid Expansion in 2014.
Mahendraratnam N; Dusetzina SB; Farley JF
J Manag Care Spec Pharm; 2017 Mar; 23(3):355-363. PubMed ID: 28230452
[TBL] [Abstract][Full Text] [Related]
13. Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018.
Sumarsono A; Lalani H; Segar MW; Rao S; Vaduganathan M; Wadhera RK; Das SR; Navar AM; Fonarow GC; Pandey A
Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e007492. PubMed ID: 33161766
[TBL] [Abstract][Full Text] [Related]
14. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
15. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
Wen H; Hockenberry JM
JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827
[TBL] [Abstract][Full Text] [Related]
16. Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018.
Lewis R; Baugher AR; Finlayson T; Wejnert C; Sionean C;
J Infect Dis; 2020 Sep; 222(Suppl 5):S420-S428. PubMed ID: 32877551
[TBL] [Abstract][Full Text] [Related]
17. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
[TBL] [Abstract][Full Text] [Related]
18. The Opioid Epidemic Blunted the Mortality Benefit of Medicaid Expansion.
Yan BW; Sloan FA; Boscardin WJ; Guo F; Dudley RA
Med Care Res Rev; 2021 Apr; 78(2):103-112. PubMed ID: 32403982
[TBL] [Abstract][Full Text] [Related]
19. Does Prescription Opioid Shopping Increase Overdose Rates in Medicaid Beneficiaries?
Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; McConnell KJ
Ann Emerg Med; 2018 Jun; 71(6):679-687.e3. PubMed ID: 29174833
[TBL] [Abstract][Full Text] [Related]
20. Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries.
Kuo YF; Baillargeon J; Raji MA
J Subst Abuse Treat; 2021 May; 124():108282. PubMed ID: 33771281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
